Electronic prescribing of controlled substances (EPCS) was adopted by the DEA to allow pharmacies to receive, dispense and archive the electronic transmission of prescriptions in a digital, trackable manner for the prescriber and the pharmacy. Essentially, it eliminates paper prescriptions.
The significance and benefits of e-prescribing was included in the federal government’s mandate, “H.R. 3528, Every Prescription Conveyed Securely Act” – the first deadline was Jan. 1, 2020.
Using appropriate technology is critical and benefits managers, pharmacies and healthcare providers must deploy appropriate software and technology to fulfill requirements to use EPCS for the Medicare Part D program, which took effect Jan. 1, 2021. However, the compliance date has been changed and set for Jan. 1, 2022, to encourage prescribers to implement EPCS sooner than later and allow physicians more time to fulfill compliance requirements without penalty.